美国安进狄诺塞麦多少钱一支？

(Denosumab) is a human RANKL monoclonal antibody (IgG2) with high affinity and specificity. It can bind to and act on RANKL, hindering the binding of RANKL on the surface of osteoclast precursor cells and mature cells, thereby inhibiting osteoclast activation and development, reducing bone resorption, and increasing bone density. The drug was approved for marketing in the United States in 2010. So, how much does one Amgen denosumab cost in the United States?

The State Food and Drug Administration conditionally approved the marketing of denosumab on May 21, 2019. As a new drug, the price of denosumab in China can be said to be quite high. The domestic price of denosumab with a specification of 120mg/1.7ml/box is around $5,300. Such a high drug price makes it prohibitive for many patients.

Overseas, a box of denosumab produced by Amgen in the United States sells for only about $1,500. Compared with the same period last year, the price of the original drug sold in China has dropped. Patients in need can, on the one hand, go abroad in person to purchase drugs locally, and on the other hand, they can also contact Medical Companion Travel to obtain their overseas drug purchase channels. Patients can also have more peace of mind and peace of mind.

After entering the 21st century, Amgen has gradually stabilized its leading position in the global biopharmaceutical field. However, as global innovative drug research and development costs rise and become more difficult, Amgen's R&D output efficiency has dropped significantly. In this regard, Amgen adopted a reasonable approach to reduce R&D investment and began to use its own huge capital chain to adopt various joint ventures or cooperation methods with other pharmaceutical companies and institutions around the world. According to the traditional expansion path of large enterprises, it acquired and merged several innovative companies with development potential to overcome the obstacles of insufficient new products and imperfect marketing networks, expand the company's technical field, and promote the continuous development and launch of new products. (Denosumab) is one of the important products it develops.

Recommended hot articles: /newsDetail/87470.html